Position in RVMD
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,614,350
New position
Shares Held
16,600
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. RVMD ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
This page
|
16,600 | $1,614,350 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,614,350 | 16,600 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||